BO with good volume and good newsThis pharma stock has given breakout with good volume
it has positive news as well i.e., gets CDSo nod for import of durvalumab for sale & distribution
If it sustains then we can dive
Happy Trading!
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
38.35 INR
1.62 B INR
12.96 B INR
4.88 M
About ASTRAZENECA PHARMA
Sector
Headquarters
Bangalore
Founded
1979
Website
ISIN
INE203A01020
FIGI
BBG000CNNKY8
AstraZeneca Pharma India Ltd. is engaged in the manufacture, distribution, and marketing of pharmaceutical products and clinical trial services. It focuses in the areas of cardiovascular and metabolic disease, cancer and respiratory, inflammatory, and autoimmune disease. The company was founded on July 11, 1979 and is headquartered in Bangalore, India.
ASTRAZENECA PHARMA S/RSupport and Resistance Levels:
Support Levels: These are price points (green line/shade) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline.
Resistance Levels: Conversely, resistance levels (re
Astrazeneca LongNSE:ASTRAZEN Weekly parabolic setup with buyers and macd momentum may continue bull run in fast and furious way.
Astrazenca Pharma- Nice BreakoutAstrazenca Pharma- Nice Breakout
Capital to be deployed- 20k
Investing Price -3943-3958
Breakout Price -3943
Stoploss -3620
Targets-4880-5142-5467
RT for max reach
#AstraZeneca #StocksToBuy #stocks #stockstowatch #StocksToTrade #SwingTrading
AstrazenAstrazen is ready for breakout either side
Mastery the price
This is only for education purpos
Astrazeneca Pharma Swing High Break*Astrazeneca Pharma*
Time Frame: daily
Observation:
* Swing High Break
* Breakout on 3284 level
Resistance/Target: 3974 4543 5124 5479
Support: 3284 3000
Head and shoulder pattern and daily volume breakoutHead and shoulder breakout
Daily volume breakout
T1: 3762
T2: 4123
SL: Right shoulder low
ASTRAZENCA BUY ABOVE @ 3000Breaking trendlines
And above 200 EMA level
pharma stock showing trend reversal
May go long based on Volume, Relative trend and Price actionAstra Zeneca, seems to reversing out of consolidation on Weekly - Testing trendline on the upside with good Marubozu candles supported by Good volume and break of RSI above NIFTY relative trend. Expect the trend to continue short - medium term, will watch next week candle before taking position.
T1
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ASTRAZEN is 6,740.65 INR — it has decreased by −5.08% in the past 24 hours. Watch ASTRAZENECA PHARMA INDIA LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange ASTRAZENECA PHARMA INDIA LTD. stocks are traded under the ticker ASTRAZEN.
ASTRAZEN stock has fallen by −12.79% compared to the previous week, the month change is a −12.70% fall, over the last year ASTRAZENECA PHARMA INDIA LTD. has showed a 45.50% increase.
ASTRAZEN reached its all-time high on Sep 30, 2024 with the price of 8,139.85 INR, and its all-time low was 114.60 INR and was reached on Oct 29, 2003. View more price dynamics on ASTRAZEN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ASTRAZEN stock is 7.60% volatile and has beta coefficient of 0.51. Track ASTRAZENECA PHARMA INDIA LTD. stock price on the chart and check out the list of the most volatile stocks — is ASTRAZENECA PHARMA INDIA LTD. there?
Today ASTRAZENECA PHARMA INDIA LTD. has the market capitalization of 178.33 B, it has decreased by −0.84% over the last week.
Yes, you can track ASTRAZENECA PHARMA INDIA LTD. financials in yearly and quarterly reports right on TradingView.
ASTRAZENECA PHARMA INDIA LTD. is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
ASTRAZEN net income for the last quarter is −117.90 M INR, while the quarter before that showed 394.77 M INR of net income which accounts for −129.87% change. Track more ASTRAZENECA PHARMA INDIA LTD. financial stats to get the full picture.
Yes, ASTRAZEN dividends are paid annually. The last dividend per share was 24.00 INR. As of today, Dividend Yield (TTM)% is 0.67%. Tracking ASTRAZENECA PHARMA INDIA LTD. dividends might help you take more informed decisions.
ASTRAZENECA PHARMA INDIA LTD. dividend yield was 0.90% in 2023, and payout ratio reached 74.30%. The year before the numbers were 0.49% and 40.29% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 14, 2024, the company has 940.00 employees. See our rating of the largest employees — is ASTRAZENECA PHARMA INDIA LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASTRAZENECA PHARMA INDIA LTD. EBITDA is 1.55 B INR, and current EBITDA margin is 14.41%. See more stats in ASTRAZENECA PHARMA INDIA LTD. financial statements.
Like other stocks, ASTRAZEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASTRAZENECA PHARMA INDIA LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASTRAZENECA PHARMA INDIA LTD. technincal analysis shows the strong sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASTRAZENECA PHARMA INDIA LTD. stock shows the buy signal. See more of ASTRAZENECA PHARMA INDIA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.